| Wulf, Sylke (Thermo Fisher 201006 Thermo Fisher Deutschland Regional Head Chromatography North) |
Regional manager |
Thermo Fisher (Group) |
Germany |
| Wulf-Fuhrmann, Gabriele (Niedersachsen (govt) 201410– Vice President of LAVES) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Wulfetange, Camilla (Scienion 201206) |
n. a. |
Cellink (Group) |
Germany |
| Wunderlin, Markus (Univ Ulm 20107 Service Center Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Ulm |
Germany |
| Wupperfeld, Udo (Leonardo Venture 2007) |
n. a. |
Leonardo Venture GmbH & Co. KGaA |
Germany |
| Wurm, Florian (ExcellGene 200905 CSO + founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ExcellGene S.A. |
Switzerland |
| Wurm, Thomas (Single Use Support 201911 Managing Director + Co-Founder) |
n. a. |
Single Use Support GmbH (SUS) |
Austria |
| Wurst, Helmut (Cellendes GmbH 200907– Managing Director + Founder) |
Managing Director |
Cellendes GmbH |
Germany |
| Wuurman, Bart (Apaxen 202011– CEO before Lyramid + Lanthio Pharma + AM-Pharma + De Novo Pharma + Antisoma) |
Chief Executive Officer (CEO) |
Apaxen S.A. |
Belgium |
| Wykeman, Nick (Allergy Therapeutics 201709 Finance Director) |
Chief Financial Officer (CFO) |
Allergy Therapeutics (Group) |
United Kingdom (GB) |
| Wünsch, Josef R. (BASF 201109 Managing Director of BASF Venture Capital GmbH) |
Managing Director |
BASF (Group) |
Germany |
| Würdemann, Chris (Ribocon 2005– co-founder) |
Company Founder |
Ribocon GmbH |
Germany |
| Würdinger, Reiner (JASCO 201204 Managing Director of JASCO Deutschland GmbH) |
Managing Director |
JASCO (Group) |
Germany |
| Würtenberger, Klaus (CorTec GmbH 201011 Managing Director) |
Managing Director |
CorTec GmbH |
Germany |
| Wyser-Pratte, Joelle (OCP Capital LLC 202010 Founder) |
Company Founder |
OCP Capital LLC |
United States (USA) |
| Wysocki, Vicki (Ohio State Univ 201509 Professor of Chemistry + Biochemistry + Head of Chemical Instrument Center) |
Professor |
Ohio State University |
United States (USA) |
| Wyss, André (Novartis –201803 President Novartis Operations LEFT 4/18) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Wyss, Lorenz (Bell Food 201807 CEO) |
Chief Executive Officer (CEO) |
Bell Food (Group) |
Switzerland |
| Wüst, Bernhard (Agilent 201909 Global Marketing Manager for Sports Doping) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Wüstenberg, Arne (Celldeg GmbH 201609– Managing Director) |
Managing Director |
Celldeg GmbH |
Germany |
| Wölfl, Stefan |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
| Xi, Hualin (Simon) (Rgenta Therapeutics 202004 CEO + CO-Founder) |
Chief Executive Officer (CEO) |
Rgenta Therapeutics Inc. |
United States (USA) |
| Xi, Zhang (Superlab Suisse 2019– CEO + Founder) |
Chief Executive Officer (CEO) |
Superlab Suisse (Group) |
Switzerland |
| Xinguang, Zhu (Chinese Academy of Sciences 201706 Prof at SIPPE) |
Professor |
China (govt) |
China |
| Xu, Caroline Man (ViGeneron 201911 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ViGeneron GmbH |
Germany |
| Xue, James (Canbridge Life Sciences 201507 CEO) |
Chief Executive Officer (CEO) |
Canbridge Life Sciences Ltd. (CN) |
|
| Yadegardjam, Farsin (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
| Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) |
Professor |
University of Kyoto (Kyoto University) |
Japan |
| Yamane, Kenji (KKR 201506 President of Panasonic Healthcare + Panasonic Healthcare Holdings) |
President/Director/Head Business Group/Unit/Division |
PHC (Group) |
Japan |
| Yanchik, Joseph A., III (Aileron Therapeutics 201008 CEO) |
Chief Executive Officer (CEO) |
Aileron Therapeutics Inc. |
United States (USA) |
| Yang, Steve (WuXi PharmaTech 201604 EVP + COO of WuXi AppTec) |
Chief Operating Officer (COO) |
WuXi PharmaTech (Group) |
China |
| Yap, Greg (Desy 201310– CEO before GE + Ventana + Cellective Dx + Affymetrix) |
Chief Executive Officer (CEO) |
Biodesy Inc. |
United States (USA) |
| Yap, Richard (Numares 201612– Managing Director of Numares Singapore before Avdisor + OrbusNeich) |
Managing Director |
Numares (Group) |
Singapore |
| Yaspo, Marie-Laure |
n. a. |
Source BioScience (Group) |
Germany |
| Yates, Robert (Merck (DE) 201109–201493 President of Merck Millipore before Roche Diagnostics LEFT 3/14) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Yee, Sidney (Singapore (govt) 201510 CEO of DxD Hub of A*STAR) |
Chief Executive Officer (CEO) |
Singapore (govt) |
Singapore |
| Yemm, Stephen (Holtzbrinck 201807 CEO of BioData Inc before Vialis 201103 Managing Director of Vialis Ltd) |
Chief Executive Officer (CEO) |
Holtzbrinck (Group) |
United States (USA) |
| Yerganian, Syrane (Strammer 201704 CFO) |
Chief Executive Officer (CEO) |
Strammer (Group) |
France |
| Yianni, John (CryoTherapeutics GmbH 201305 Managing Director) |
Managing Director |
CryoTherapeutics GmbH |
Germany |
| Yildiz, Marius (Murat) (Avergen Pharmaceuticals GmbH 201510– Managing Director) |
Managing Director |
Avergen Pharmaceuticals GmbH (APG) |
Germany |
| Ylisaukko-oja, Tero (MedEngine Oy 201901 CEO) |
Chief Executive Officer (CEO) |
|
|
| Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Germany |
| Yoshitaka, Shinsuke (Denka 201508 President + CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Japan |
| Young, Diane (Novartis Oncology 200601) |
n. a. |
Novartis (Group) |
Switzerland |
| Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
| Yousaf, Shaf (Sigma-Aldrich 201412 VP Tech + BusDev before Life Technologies + Applied Biosystems + Sigma-Aldrich) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Yrjänheikki, Juha (Aurealis Pharma 201708 CEO) |
Chief Executive Officer (CEO) |
Aurealis Pharma AG |
Switzerland |
| Yu, Chen (Vivo Capital 201504 Managing Partner) |
Managing Partner (investment firm) |
Vivo Capital (US/CN) |
United States (USA) |
| Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) |
Chief Executive Officer (CEO) |
Ally Bridge Group (ABG) |
China |
| Yu, Guo-Liang (Epitomics 201105 CEO) |
Chief Executive Officer (CEO) |
Abcam (Group) |
United States (USA) |
| Yusibov, Vidadi (Fraunhofer USA 201009 Exec Director CMB + iBio 201009 CSO) |
Researcher (university / research institute) |
Fraunhofer (Group) |
United States (USA) |
| Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
| Yzer, Cornelia (Berlin (govt) 201305 Senator of Economy, Technology, and Research) |
Minister |
Berlin (govt region) |
Germany |
| Zabel, Nina (BioRegio STERN 201802–) |
Cluster Manager |
BioRegio STERN Management GmbH |
Germany |
| Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Zaby, Andreas (Curacyte 200601) |
n. a. |
Curacyte (Group) |
Germany |
| Zacharias, Dietmar (Hochschule Bremen 201303 Professor for Applied + Ecological Botanics) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Zachert, Matthias (Lanxess 201401– CEO before Merck (DE) CFO) |
Chief Executive Officer (CEO) |
Lanxess (Group) |
Germany |
| Zachmann, Julian (High-Tech Gründerfonds 202008 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Zafirakos, Elias (BioPeople (DK) 201404 Science Liaison Officer) |
Cluster Manager |
Biopeople (Denmark’s Life Science Cluster) |
Denmark |
| Zahn, Dorothea (BST Bio Sensor Technology GmbH 201110 Managing Director) |
Managing Director |
BST Bio Sensor Technologie GmbH |
Germany |
| Zahn, Grit (Eternygen GmbH 201309– Head of Research before ipal GmbH + Jerini) |
Research & Development Manager |
Eternygen (Group) |
Germany |
| Zahn, Ralph (Biocrates 201306 CTO) |
Chief Technology/Technical Officer (CTO) |
Biocrates (Group) |
Austria |
| Zahnd, Christian (Molecular Partners 200708 CEO) |
Chief Executive Officer (CEO) |
Molecular Partners AG (SIX: MOLN) |
Switzerland |
| Zambon, Elena (Zambon 201907 President) |
Board member |
Zambon (Group) |
Italy |
| Zamboni, Nicola (ETH Zurich 201007 Institute of Molecular Systems Biology) |
Researcher (university / research institute) |
ETH Zürich (ETHZ) |
Switzerland |
| Zampieri, Gianni (Galenica Group 201702 CEO of Vifor Pharma) |
Chief Executive Officer (CEO) |
Vifor Pharma (Group) |
Switzerland |
| Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) |
Chief Executive Officer (CEO) |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Zanzinger, Johannnes (Boehringer 202001 at BIVF) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Zapico, David A. (AMETEK 201608 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
| Zarrehparvar, Mazi (MicrobeDx 201701 CEO) |
Chief Executive Officer (CEO) |
MicrobeDx (Group) |
United States (USA) |
| Zauderer, Maurice (Vaccinex 200803 CEO) |
Chief Executive Officer (CEO) |
Vaccinex Inc. |
United States (USA) |
| Zazulina, Victoria (Boehringer 201908 Corporate VP + Global Head of Oncology Medicine) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Zbar, Brett (General Atlantic 202009– Managing Director + Global Head Life Sciences before Foresite Capital + Aisling) |
Managing Director |
General Atlantic (Group) |
United States (USA) |
| Zech, Birgit (Gotham Therapeutics 201708– COO before X-Rx + MAB Discovery + Pieris + Axxima) |
Business Development Manager / Strategy Manager |
Gotham Therapeutics (Group) |
Germany |
| Zechner, Rudolf (Univ Graz 201308 Professor at Instittue for Molecular Biosciences) |
Professor |
University of Graz (Karl-Franzens-Universität) |
Austria |
| Zehethofer, Karl |
n. a. |
Greiner (Group) |
Austria |
| Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) |
Board member, executive |
Endress+Hauser (Group) |
Switzerland |
| Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zeinali, Sirous (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
| Zeise, Antje (Epigenomics 201112 Manager IR | PR) |
Public Relations Manager / Investor Relations Manager |
Epigenomics (Group) |
Germany |
| Zell, Andreas |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Zeller, Marco (VC Fonds Berlin 200508 Managing Director) |
Managing Director |
Berlin (govt region) |
Germany |
| Zeltner, Jürg (UBS 201604 President of UBS Wealth Management) |
President/Director/Head Business Group/Unit/Division |
UBS (Group) |
Switzerland |
| Zeltz, Patric (BadenBioTec 201104 Managing Director before BF-Biolabs 200312– founder) |
Managing Director |
BadenBioTec GmbH |
Germany |
| Zencke, Peter (MeVis Medical Solutions 200708–201106 Supervisory Board Member) |
Supervisory Board Member |
Varian Medical Systems (Group) |
Germany |
| Zenker, Matthias (GAIA 201702 Business Development) |
Business Development Manager / Strategy Manager |
GAIA AG |
Germany |
| Zenker, Othmar (InflaRx 201706– CMO before Head Clinical Research + Development since 2013 before CSL Behring) |
Research & Development Manager |
InflaRx (Group) |
Germany |
| Zenobi, Renato (ETH Zürich 201006 Professor Dept of Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Zentgraf, Martin (Desitin 201202 General Manager of Desitin Arzneimittel GmbH) |
General Manager (management) |
Desitin Arzneimittel GmbH |
Germany |
| Zepp, Tobias (CRS Clinical Research Services 201706 Corporate Communications Manager) |
Public Relations Manager / Investor Relations Manager |
CRS Clinical Research Services (Group) |
Germany |
| Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
France |
| Zerrer, Ralf (Clariant 201801 Head Strategic Marketing + Innovation at Business Unit Industrial + Consumer Specialties) |
Sales Manager / Marketing Manager |
Clariant (Group) |
Switzerland |
| Zettl, Rolf (Combinature co-founder + CEO 200011–200504 afterwards CBO) |
Chief Business Officer (CBO) |
MerLion (Group) |
Germany |
| Zettl, Rolf (Helmholtz 201502 Managing Director) |
Managing Director |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) |
Business Development Manager / Strategy Manager |
CEBINA GmbH (Central European Biotech Incubator and Accelerator) |
Austria |
| Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
| Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) |
Managing Director |
Bremen (govt region) |
Germany |
| Zeyer, Denis (Novalix 201011 CEO) |
Chief Executive Officer (CEO) |
Novalix (Group) |
France |
| Zeyfang, D. |
n. a. |
DaimlerChrylser (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 73 74 75 
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
